Testing effectiveness (Phase 2)Study completedNCT01427699
What this trial is testing
The Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Janssen Research & Development, LLC 7